Mach7 Technologies Limited
TDMMF
Other OTC0.24
USD
- -
- -
ISIN
AU000000M7T0
Return %
Stock
S&P500
1Y
-1.17
26.84
3Y
-34.11
77.03
5Y
-71.07
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Teri Jo Thomas
- Full Time Employees
- 58
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 120 Kimball Avenue South Burlington VT United States of America 05403
- IPO Date
- Dec 31, 2015
- Website
- mach7t.com
- Similar Companies
- Business
- Mach7 Technologies Limited (ASX:M7T; OTC:TDMMF) develops and commercializes enterprise medical imaging software solutions that enable healthcare organizations to manage, share, store, and interoperate clinical imaging and multimedia data across departments, sites, and vendors worldwide. The company offers a vendor-neutral platform including eUnity Enterprise Diagnostic Viewer for zero-footprint viewing and integration; Enterprise PACS for consolidated radiology imaging; vendor neutral archiving (VNA); UnityVue, a unified radiology workflow suite integrating image acquisition, worklists, and reporting; intelligent AI capabilities leveraging Strings for self-healing IT operations, workflow automation, and predictive analytics; enterprise data management for cross-workflow capture, indexing, distribution, and analysis; and professional services encompassing training, project management, clinical applications, support, and maintenance. Founded in 2007 and headquartered in South Burlington, Vermont, Mach7 Technologies operates primarily in North America, Asia-Pacific, the Middle East, and Europe, serving academic medical centers, multi-site health networks, and government entities with subscription-based recurring revenue models. Recent developments include a five-year A$10.2 million renewal contract with Sentara Healthcare for its Enterprise Imaging Platform and PACS services in December 2023; a five-year extension worth HK$81 million (A$15 million) with Hong Kong's Hospital Authority in September 2023 for VNA, eUnity support, and professional services; the launch of UnityVue in collaboration with NewVue announced ahead of RSNA 2025; establishment of a lower-cost engineering innovation hub in Asia to scale development and support high-growth markets; appointment of a Chief Innovation Officer to unify product and engineering teams; Q1 FY26 sales orders of A$2.6 million and annual recurring revenue run rate of A$23.5 million as of September 2025; and reaffirmed FY25 guidance projecting 15-25% revenue growth with operating expenditure increases below revenue levels.
Mach7 Technologies to Showcase Enterprise Imaging Innovation and New eUnity Digital Pathology Capabilities at SIIM26
Mach7 Technologies Limited (TDMMF) Q3 2026 Earnings Call Transcript
Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call Transcript
Mach7 Technologies Limited (TDMMF) Q2 2026 Earnings Call Transcript
Mach7 Technologies Limited (TDMMF) Shareholder/Analyst Call Transcript
Mach7 Technologies Launches New Flight Path for Medical Imaging - "from Archive to Architecture" at RSNA 2025
Mach7 Technologies Limited (TDMMF) Q1 2026 Earnings Call Transcript